Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Manic Episode”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Large-scale testing (Phase 3)Study completedNCT00253162
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 439
Post-approval studies (Phase 4)Study completedNCT00602537
What this trial is testing

Antidepressant Therapy in Treating Bipolar Type II Major Depression

Who this might be right for
Bipolar DisorderDepression
University of Pennsylvania 140
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT00257075
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisordersManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267
Not applicableLooking for participantsNCT06804525
What this trial is testing

LHC-CIDI-5 in Hong Kong

Who this might be right for
Major Depressive Episode (MDE)Major Depressive Disorder (MDD)Persistent Depressive Disorder (PDD)+20 more
The University of Hong Kong 2,500
Not applicableUnknownNCT05622552
What this trial is testing

Effect of tDCS Combined With Pharmacological Treatments for Bipolar Mania

Who this might be right for
Manic Episode
Dongbin Lyu 70
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Post-approval studies (Phase 4)Study completedNCT00961961
What this trial is testing

Prevention of Relapse & Recurrence of Bipolar Depression

Who this might be right for
Bipolar Disorder
University of Pennsylvania 177
Large-scale testing (Phase 3)Study completedNCT00238485
What this trial is testing

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Novartis 251
Large-scale testing (Phase 3)Study completedNCT00271258
What this trial is testing

Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents

Who this might be right for
Bipolar Disorder
Sanofi 200
Large-scale testing (Phase 3)Study completedNCT00107939
What this trial is testing

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Who this might be right for
Bipolar Disorder
Novartis Pharmaceuticals 453
Large-scale testing (Phase 3)Study completedNCT00266630
What this trial is testing

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Manic or Mixed Episode Associated With Bipolar I Disorder
Eli Lilly and Company 139
Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Not applicableStudy completedNCT05956340
What this trial is testing

Spoken Language in Mania

Who this might be right for
Manic EpisodeBipolar I Disorder
Mayo Clinic 17
Large-scale testing (Phase 3)Study completedNCT00159796
What this trial is testing

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

Who this might be right for
Bipolar Disorder
Organon and Co 489
Large-scale testing (Phase 3)Looking for participantsNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Load More Results